SAO PAULO, BRAZIL - A new HIV prevention drug, lenacapavir, is being called a major breakthrough. The WHO has released new ...

In rural India, mycetoma—a painful, neglected disease from minor wounds—cripples workers, causing disability, poverty, and stigma. Delayed diagnosis and costly treatment worsen the crisis.

Thailand is examining the feasibility of adopting new global guidelines on long-acting HIV prevention, following the World Health Organisation's (WHO) launch of its latest recommendations for ...

Although the FDA approval of lenacapavir as a twice-yearly form of preexposure prophylaxis (PrEP) is “momentous,” cost and access curb excitement, according to Jeremiah Johnson, executive director of ...